Digital Data DNA Graphic


2023 Biotechnology Conference

March 16, 2023
9:00 AM – 5:00 PM

16 W. 61st St., 11th Floor
New York, NY

Regenerative Medicine: Improving the Way We Live, Play and Feel

New York Tech's 2023 Biotechnology Conference: Regenerative Medicine: Improving the Way We Live, Play and Feel, will gather recognized leaders, top global researchers, and medical professionals, plus innovators in the healthcare and biotechnology sectors. Companies and New York Tech faculty will describe their latest state-of-the-art innovations and cutting-edge research transforming and improving the human condition. Government officials and investors will discuss how to tap into financial resources to fund your startup and accelerate your company’s growth. This is a must-attend event for experts, industry peers, and like-minded people to form new relationships and strengthen existing ones.

View Past Conferences Live Streams

2023 Sponsors and Supporters

Become a Sponsor

Are you interested in sponsoring this year’s event and providing your support to current and future New York Tech students? Learn more about sponsorhip options:

  • 6 conference registrations including cocktail reception
  • 1 Exhibit Table at the Biotechnology Conference
  • 1 Reserved spot at an upcoming New York Tech Career fair in academic year 2023-24.
  • Signage at the Biotechnology Conference
  • Linked logo on the Biotechnology Conference webpage and at Career Services for one year
  • Recognition from podium during opening remarks at the Biotechnology Conference
  • Full page ad in the Biotechnology Conference

Fair market value of goods is $600. Your donation to New York Tech is $9,400.

Become a Sponsor

  • 4 conference registrations including cocktail reception
  • 1 Exhibit Table at the Biotechnology Conference
  • Your company logo on display at Career Services for one year
  • Linked logo on Biotechnology Conference
  • Recognition from podium during opening remarks

Fair market value of goods is $400. Your donation to New York Tech is $4,600.

Become a Sponsor

  • 2 conference registrations including cocktail reception
  • 1 Exhibit Table at the Biotechnology Conference
  • Linked logo on conference webpage for one year
  • Logo in the printed program

Fair market value of goods is $200. Your donation to New York Tech is $2,300.

Become a Sponsor

  • 1 conference registrations including cocktail reception
  • Exhibit Table at the Biotechnology Conference
  • Linked logo on the Biotechnology Conference webpage for one year
  • Logo in the printed program

Fair market value of goods is $100. Your donation to New York Tech is $900.

Become a Sponsor

  • Exhibit Table at the Biotechnology Conference
  • Sponsor 2 students to attend the Biotechnology Conference
  • Linked logo on the Biotechnology Conference webpage for one year
  • Logo in the printed program.

Fair market value of goods is $200. Your donation to New York Tech is $300.

Become a Sponsor


Each sponsorship will include logo recognition on the Biotechnology Conference webpage for one year, in the printed program (subject to print deadline), and onsite signage at sponsored location(s).

  • Lunch Sponsor - $3,000 (3 available)
  • Conference Break Sponsors - $1,500 (2 available)
  • Cocktail Reception Sponsor - $5,000 (2 available)

Your donation to New York Tech is in the full amount of your sponsorship.

Become a Sponsor

  • Logo submission deadline is Friday March 10, 2023

  • For more information, please contact Victoria Greco at or 516.686.7848.


9:30 a.m.

Breakfast and Networking

10 a.m.

Welcome Remarks

10:15 a.m.

Keynote Address: Human Heart Regeneration is an Imminent Reality

Hina W. Chaudhry, M.D., Professor of Medicine and Cardiology, Director of Cardiovascular Regenerative Medicine, Icahn School of Medicine at Mount Sinai

10:50 a.m.

LifeSciNYC: An Investment in New York City’s Life Sciences

Kyle Kaniecki, Ph.D., Vice President of Life Sciences and Healthcare, New York City Economic Development Corporation (NYCEDC)

11:15 a.m.

Cardiac Regeneration: Replicating Fundamental Properties of Adult Mammalian Myocardium will be Challenging. What are we up against?

A. Martin Gerdes, Ph.D., Professor, Chair of the Department of Biomedical Sciences, NYIT College of Osteopathic Medicine

11:35 a.m.

Panel Presentation: Startups

Moderator: Dean Babak Beheshti, Ph.D., College of Engineering and Computing Sciences, New York Institute of Technology

  • David Lewandowski, Director, Business Development Cell and Gene Therapy, Azenta Life Sciences
  • Filippos Tourlomousis, Ph.D., Founder, Biological Lattice Industries
  • Ross O. Youngs, CEO and Founder, BioSortia Microbiomics
  • Paul Marshall, Chief Executive Officer and Co-founder, Rapid Fluidics Ltd.

12:15 p.m.

Fireside Chat

Host: John Pennett, CPA, Partner-in-Charge of the National Technology and Life Sciences Group, EisnerAmper

  • George S. Goldberger, Founder and Chief Executive Officer, Cell One Partners

12:45 - 1:30 p.m.


Virtual Keynote Address

Scott Rodeo, M.D., Hospital for Special Surgery, Director of the Center for Regenerative Medicine (Recorded message)

1:30 p.m.

Super-Resolution Microscopy for Discovery at the Frontier of Cell Biology

Randy Stout, Ph.D., Associate Professor, Department of Biomedical Sciences; Director, NYITCOM Center for Biomedical Innovation and NYIT Imaging Center, NYIT College of Osteopathic Medicine

1:50 p.m.

Regenerative Medicine for the Musculoskeletal System

Daniel Savarino, D.O. (’05), Founder, Apex Sports and Regenerative Medicine

2:15 p.m.

Speaker: Regenerative Medicine Strategies for Repair of the Musculoskeletal System

Daniel A. Grande, Ph.D., Professor of Orthopaedic Surgery, Molecular Medicine, Urogynecology and Otolaryngology; Director, Orthopaedic Research Laboratory; Associate Director Research, OrthoBiologics Center at Northwell Health

2:40 p.m.

Panel Presentation:

Moderator: Michael Nizich, Ph.D., M.S., Director, Entrepreneurship & Technology Innovation Center (ETIC) and Cyber Defense Education at New York Institute of Technology

  • Carmella Stephens, Ph.D., Esq., Partner, Carter, DeLuca & Farrell LLP
  • James (Jimmy) Lu, Founder and Managing Director, EOS BioInnovation, a Regenerative VC Fund
  • Charles Goulding, Esq., CPA, President, R&D TaxSavers
  • John Pennett, CPA, Partner-in-Charge of the National Technology and Life Sciences Group at EisnerAmper

3:30 p.m.

Speaker: Introduction to Alexandria & NYC Life Science Ecosystem Engagement

Cat Donaldson. Ph.D., M.B.A, Executive Director, LaunchLabs NYC at Alexandria Real Estate Equities, Inc.

3:45 p.m.

Networking Break (coffee/snacks)

4 p.m.

Speaker: Translating Discoveries into Medical Products

Richard McFarland, Ph.D, M.D., Chief Regulatory Officer, ARMI

4:20 p.m.


Brooke Grindlinger, Ph.D., Chief Scientific Officer, New York Academy of Sciences

4:35 p.m.

Nanobiotechnology and Biomaterials in Medicine

Azhar Ilyas, Ph.D., Assistant Professor, Department of Electrical and Computer Engineering, New York Institute of Technology

5 p.m.

Closing Remarks

Chad Bouton, M.D., Vice President of Advanced Engineering and Director of the Neural Bypass and Brain Computer Interface Laboratory, The Feinstein Institutes for Medical Research at Northwell Health

5:30 - 6:30 p.m.

Networking Reception

Entrepreneurship and Technology Innovation Center (ETIC): Demonstrations of Innovative Technologies

The agenda is subject to change

Keynote Speaker

Hina W. Chaudhry

Hina W. Chaudhry, M.D, is the Director of Cardiovascular Regenerative Medicine and is also a developmental geneticist with expertise in cell cycle biology, stem cell biology, and regenerative biology. She received her M.D. from Harvard Medical School.

In her presentation, "Human Heart Regeneration is an Imminent Reality," "Chaudhry will speak about her team's efforts at regenerating the human heart utilizing both cell cycle manipulation to enhance cardiomyocyte proliferation and a novel source of multipotent stem cells her lab has discovered that they are isolating from human term placentas.

Luncheon Keynote

Scott Rodeo

Scott Rodeo, M.D. is Professor of Orthopaedic Surgery at Weill Medical College of Cornell University and is an Attending Surgeon at the New York-Presbyterian Hospital and Hospital for Special Surgery, where he is Co-Chief Emeritus of the Sports Medicine and Shoulder Service, Vice Chair of Orthopaedic Research, and Co-Director of the Orthopaedic Soft Tissue Research Program.

He also serves as Director of the Center for Regenerative Medicine at Hospital for Special Surgery. Rodeo is Head Team Physician for the New York Giants Football Team, and he served as a Team Physician for the United States Olympic Team in 2004, 2008, 2012, and 2016.

Read More

His clinical practice involves orthopaedic sports medicine, with specialty interest in complex knee reconstruction (ligament, meniscus and cartilage surgery), tendon repair in the shoulder and other joints, and shoulder instability. He runs a translational research laboratory program investigating the cellular and molecular mechanisms of soft tissue repair. Rodeo graduated cum laude from Stanford University, where he completed his undergraduate work while competing on the Stanford Swimming Team. He completed medical school graduating with honors from Cornell University Medical College.

Speakers and Panelists

Babak Beheshti

Babak Beheshti, Ph.D., Dean, NYIT College of Engineering and Computing Sciences

Babak D. Beheshti, Ph.D. is Professor and Dean of the College of Engineering and Computing Sciences (CoECS) at New York Institute of Technology.

Babak’s experience in higher education spans over 35 years, where he has served as a full-time faculty member, President of the Senate, Associate Dean, and Dean. As dean of the engineering college, Babak led the college to the introduction of its first two Ph.D. programs in computer science and engineering, two new Bachelor’s and one new Master's degree programs, in addition to leading the college through its fastest climb in national rankings: #33 Best Undergraduate Engineering Programs (National - no doctorate) – a climb of 13 places since 2020, and #191 Best Computer Science Undergraduate Programs (National - no doctorate), a new ranking in 2021– a climb of 40 places since 2020.

Full Bio »

Chad Bouton

Chad Bouton , M.D., Vice President of Advanced Engineering and Director of the Neural Bypass and Brain Computer Interface Laboratory, The Feinstein Institutes for Medical Research at Northwell Health

Prior to joining the health system, Chad Bouton was a research leader at Battelle, the world’s largest nonprofit research and development (R&D) organization, and was involved in medical device R&D programs for 18 years. He developed cancer detection algorithms in the late 1990s to help surgeons pinpoint and remove tumors more effectively. Later, he developed neural decoding methods that allowed the first paralyzed person with a brain implant to move again with their own thoughts.

Read More

Bouton’s work has been featured on 60 Minutes and at TEDx, and he holds more than 70 patents worldwide. He has been awarded two R&D 100 Awards and was recognized by Congress for his work in the medical device field. He has been named Inventor of the Year and Distinguished Inventor by Battelle, and was selected by the National Academy of Engineering in 2011 to attend the Frontiers in Engineering Symposium. Bouton received his B.S. in Electrical Engineering at Iowa State University and his M.S. in Engineering Mechanics at Iowa State University with Honors.

Cat Donaldson

Cat Donaldson, Ph.D., M.B.A, is Executive Director of Alexandria Real Estate’s flagship LaunchLabs incubator at the Alexandria Center for Life Sciences in NYC. In this role, Cat is focused on running NYC’s premier life sciences incubator, shepherding, and supporting new company creation and growth, and engaging with the NYC entrepreneurship ecosystem. Previously, Cat was Chief Development Officer at Cold Spring Harbor Laboratory, developing scientific programs and leading resourcing strategy for the world-renowned life sciences research institute on Long Island, NY. Throughout her career, Cat has spearheaded and fostered many multimillion-dollar research initiatives, spanning academic research and educational programs and start-up companies. Cat is fundamentally motivated by facilitating and accelerating the real-world impact of innovation and discovery in the life sciences.

Read More

Cat received her Ph.D. in Biochemistry from the University of Cambridge in the UK, and completed a post-doctoral fellowship at Stony Brook Medicine, NY. She has an MBA in Healthcare Management from Stony Brook University and is co-author on several peer-reviewed publications and patents. Cat is a member of the Advisory Council of the UK Research Integrity Office (UKRIO). She is on the review committee for Rockefeller University’s Robertson Therapeutic Development Fund and New York University’s Endless Frontier Labs.

A. Martin Gerdes

A. Martin Gerdes, Ph.D., Professor/Department Chair Biomedical Sciences, NYITCOM College of Osteopathic Medicine

After developing and validating accurate techniques to assess changes in cardiac myocyte shape and number, Martin Gerdes, Ph.D., defined how these cells remodel in physiological and pathological conditions. He demonstrated that the dilated, thin-walled ventricle characteristic of systolic heart failure was due to a maladaptive change in myocyte shape (increased length with no change in diameter) rather than slippage of myocytes past each other. In addition, Gerdes showed that chronic hypothyroidism alone can eventually lead to dilated heart failure with a maladaptive change in myocyte shape and impaired coronary blood flow. His research has shown that serum thyroid hormone levels may underestimate the true incidence of low cardiac tissue hormones in heart disease.

Full Bio »

Daniel A. Grande

Daniel A. Grande, Ph.D. graduated from Long Island University with a BS in biology and completed his PhD in anatomy and cell biology at New York University. He completed his post-doctorate in biomechanics at the Hospital for Special Surgery. He began his scientific career at the Hospital for Joint Diseases/Orthopedic Institute studying regenerative medicine and tissue engineering technologies for repair of the musculoskeletal system. In 1990, Dr. Grande established the orthopedic research laboratory at the Feinstein Institutes for Medical Research and continues investigating novel regenerative therapies including stem cells, growth factors, biomaterials and 3D bioprinting.

Brooke Grindlinger

Brooke Grindlinger, Ph.D. serves as the Chief Scientific Officer at the New York Academy of Sciences.

In this role, Brooke leads strategic development and scientific oversight of the Academy's international portfolio of scientific conferences and related multimedia publications across the broad spectrum of Life Sciences, Physical Sciences, Chemistry, Sustainability, Computer Science, and Engineering. Through this platform — and via strategic alliances with external organizations, foundations, and individuals — the Academy convenes leading international scientists from academia, industry, and government sectors in focused efforts to catalyze advances in science, medicine, engineering, and innovation for the benefit of society.

Read More

Brooke also stewards the Blavatnik Awards for Young Scientists and Innovators in Science Award prize programs — two of the largest unrestricted awards ever created for young scientists. The first, established in 2007 with the support of the Blavatnik Family Foundation, honors exceptional young scientists and engineers in the USA, Israel, and United Kingdom by celebrating their extraordinary achievements, recognizing their outstanding promise, and accelerating innovation through unrestricted funding. The second, recognizes promising Early-Career Scientists and outstanding Senior Scientists contributions to science in the therapeutic areas of Neuroscience, Gastroenterology, Regenerative Medicine, Rare Diseases, and Oncology, and is intended to support their commitment to innovative research. In April 2021 Brooke was named by Crain’s New York Business as a “Most Notable in Nonprofits and Philanthropy” for her work to provide educational programs that served the scientific community and general public as a crucial clearinghouse of accurate, verified data, and analysis about the COVID-19 pandemic.

Azhar Ilyas

Azhar Ilyas, Ph.D., Assistant Professor, Department of Electrical and Computer Engineering, College of Engineering & Computing Sciences, New York Institute of Technology (NYIT)

Azhar Ilyas is an assistant professor of electrical and computer engineering. Prior to joining New York Tech, he was a post-doctoral fellow at Texas A&M University in the Department of Biomedical Sciences. He received his Ph.D. in electrical engineering from the University of Texas at Arlington in 2013. His research experience and interests are in the general areas of biomedical engineering, nanoscience, and nanotechnology, with a particular focus towards their application in disease diagnostics and bone regeneration.

In 2016, Ilyas came to New York Tech, where he established the Bio-Nanotechnology and Biomaterials (BNB) Laboratory. The research in this lab focuses on two major themes: 1) point-of-care disease diagnostics; and 2) osteoinductive materials for bone-implant systems.

Full Bio »

Kyle Kaniecki

Kyle Kaniecki, Ph.D., Vice President of Life Sciences and Healthcare at the NYC Economic Development Corporation (EDC).

In his role at the EDC, Dr. Kaniecki works to help implement the mayor’s $1B LifeSci NYC initiative to create jobs and establish New York City as a global leader in life sciences. Before joining the EDC, Dr. Kaniecki was an entrepreneur at a clinical-stage pharmaceutical company based in NYC, worked at Columbia University’s tech transfer office, and has a long history working in academic research and drug development. Dr. Kaniecki has a B.S. in Zoology from UW-Madison, an M.S. in Biotechnology from Johns Hopkins University, and a Ph.D. in Genetics and Development from Columbia University.

David Lewandowski

David Lewandowski, Director, Business Development Cell and Gene Therapy, Azenta Life Sciences.

In his current role at Azenta Life Sciences, he drives industry conversation around and scale up for cell and gene therapy distribution models including R&D, manufacturing, and distribution of final products. As a past ISBER President (Intl Society for Biological and Environmental Repositories), he established a partnership with the Society for Cryobiology to develop the first Liquid Nitrogen-Based Storage Facility Best Practices. Currently he is a co-chair for the ISCT (Intl Society for Cell Therapy) Cold Chain Management & Logistics Working Group and is passionate about supporting discussions related to scaling cryogenic distribution models from the factory to the pharmacy.

Richard McFarland

Richard McFarland, Ph.D., M.D., Chief Regulatory Officer of ARMI/BioFabUSA

Prior to ARMI he was Associate Director of Policy for FDA/CBER’s Office of Tissues and Advanced Therapies and its predecessor office, the Office of Cellular, Tissue and Gene Therapies. In this position, he was heavily involved in policy development for tissue engineering, regenerative medicine, and alternatives to animal use in regulatory decision making. Dr. McFarland received his B.S., Ph.D., and M.D. from the University of North Carolina at Chapel Hill, and completed his anatomic/clinical pathology residency and immunopathology fellowship training at UT Southwestern in Dallas.

Michael Nizich

Michael Nizich, Ph.D., Director of the Entrepreneurship and Technology Innovation Center (ETIC), New York Institute of Technology

Michael Nizich is the director of the Entrepreneurship and Technology Innovation Center (ETIC) and an adjunct assistant professor of computer science at New York Institute of Technology. He has more than 25 years of professional experience in information technology in a variety of industries, including aviation, education, law enforcement, biotechnology, and cybersecurity. Nizich has held IT leadership positions in both private and publicly held companies.

Full Bio »

John Pennett

John Pennett, Partner, Eisner Advisory Group LLC

Pennett is the Partner-in-Charge of the National Technology and Life Sciences Group. He has 35 years of public accounting experience, with a strong emphasis on public and private life science and technology companies. John is a frequent writer and speaker on industry topics. He is the publisher of Catalyst, a newsletter focused on delivering informative content on both business and technical issues affecting entrepreneurs in the technology and life sciences space.

Full Bio »

Daniel Savarino

Daniel Savarino, D.O., an established and highly skilled physician, has over 10 years of experience in Sports Medicine. He obtained his medical degree at the New York College of Osteopathic Medicine and completed a Family Practice Residency at North Shore – LIJ Hospital at Plainview, where he served as Chief Resident from 2007-2008.

Dr. Savarino’s practice Apex Center for Regenerative Medicine is the first in the State of New Jersey to provide the Emsculpt NEO, a non-invasive body shaping procedure that provides simultaneous fat elimination and muscle building. Dr. Savarino has become a Clinical Trainer and Mentor for the BTL (Emsculpt NEO) as well as BioTE (hormones). His practice is now an Academic Center, where he works with and trains other medical professionals on these procedures.

Read More

At the completion of his residency, Dr. Savarino covered the orthopedic, trauma, pediatric, sports and total joint clinic at Nassau University Medical Center, an active Level 1 Trauma Center in Long Island, NY. Dr. Savarino completed a Sports Medicine Fellowship at North Shore -LIJ Plainview, at which time he worked with 2 NCAA colleges and several local high schools, covering multiple sports from the sidelines and treating injured patients in the training room. He also covered major events including the NYC Marathon, NYC Triathalon, Long Island Marathon and Golden Gloves Boxing.

Before starting Apex Center For Regenerative Medicine, Dr. Savarino worked in one of the busiest Orthopedic and Sports Medicine practices in New York City. During that same time, he performed over 10,000 procedures including Tenex, PRP (Platelet enriched plasma), stem cells and ultrasound guided injections, making him one of the most experienced practitioners in his specialty. Patients have traveled from different parts of America and from different countries to be treated by him.

Dr. Savarino went on to receive his RMSK. The Registered in Musculoskeletal® (RMSK®) sonography certification is the highest standard of musculoskeletal ultrasound practice and promotes best practices for enhanced patient safety. By earning the musculoskeletal ultrasound certification, Dr. Savarino has demonstrated cutting-edge knowledge and skills needed to provide top care to his patients.

Keeping in line with his desire to stay on the cutting edge, Dr. Savarino has expanded his scope of practice to include NON-SURGICAL AESTHETICS, BODY CONTOURING, AGE MANAGEMENT MEDICINE, BIO-IDENTICAL HORMONE REPLACEMENT and MEDICAL WEIGHT LOSS. He has received hundreds of hours of additional training in these procedures in order to provide the best and most advanced care.

Never one to rest on his laurels, Dr. Savarino continues to expand his skills learning the most advanced regenerative and non-surgical procedures to help his patients look and feel great without the need for surgery and the lengthy recovery associated. At Apex Center for Regenerative Medicine, we have a firm belief that most surgeries can be avoided by using the latest technologies and advanced procedures. Don’t Operate, Regenerate.

Carmella L. Stephens

Carmella L. Stephens, Ph.D., Partner, Carter, DeLuca & Farrell LLP

Carmella L. Stephens, a patent attorney with over 25 years experience, counsels a wide range of clients including biotechnology and pharmaceutical corporations as well as academic institutions on issues relating to biotech and pharmaceutical patents. Her experience includes development and management of complex U.S. and foreign patent portfolios based on assessment of the client’s business interests. The majority of her patent practice focuses on patent prosecution, IP due diligence, and preparation of opinions relating to patent eligibility, validity, infringement, and freedom-to-operate.

Read More

Stephens’ patent practice covers an array of different life science technologies including those relating to endonuclease based genome editing systems; immunobiology; diagnostic and prognostic tests based on gene expression profiles; viral based expression systems for use in gene therapy; and stem cell-based therapies, to name a few.

Prior to pursuing a legal career, Stephens received her Ph.D. from SUNY Stony Brook after the completion of her thesis research at Cold Spring Harbor Laboratory followed by a post-doctoral fellowship conducted at Memorial Sloan Kettering Cancer Center. Her technical background in the life sciences provides her with the ability to successfully interface with scientists to maximize protection of their intellectual property.

Filippos Tourlomousis

Filippos Tourlomousis, Ph.D.. Founder of Biological Lattice Industries, and, as reported in MIT News, the inventor of a new way of making “scaffolding for biological cultures that could make it possible to grow cells that are highly uniform in shape and size, and potentially with certain functions. The new approach uses an extremely fine-scale form of 3-D printing, using an electric field to draw fibers one-tenth the width of a human hair.